Cancel
Known information
- Was most recently chief business officer at REGENXBIO
- Had accountability for corporate development, commercial planning, portfolio strategy, alliance management, and corporate communications at REGENXBIO
- Was a vice president at bluebird bio
- Had accountability for new product planning, program management, patient advocacy, and external affairs at bluebird bio
- Held roles of increasing global commercial leadership at Genzyme Corporation
- Helped launch multiple first-in-class enzyme replacement therapies for rare diseases at Genzyme Corporation
- Started career at General Electric
- Held technical roles at GE Healthcare and business assignments at GE Corporate
- Received an MBA from Harvard Business School
- Received a B.S. from Stanford University
- Was appointed to the Board of Directors for The Alliance for Regenerative Medicine (ARM) in 2022
About Tenaya Therapeutics
Tenaya Therapeutics develops gene therapies and precision medicines for heart disease, founded by leading cardiovascular scientists.
Report inaccurate information
